Metabolic Risk Articles & Analysis
5 articles found
This type of inflammation specifically results from noncardiac metabolic risk factors, including obesity, diabetes, anemia, hypertension, chronic obstructive pulmonary disease (COPD), auto-immune diseases, and renal insufficiency. [4] Other Key Differences Between HFpEF and HFrEF: Risk Factors, Diagnosis, and Treatment Risk ...
We have proposed a novel combinatorial approach using FDA approved compounds targeting IL-17a and DPP4 to ameliorate a significant portion of the clustered clinical risks in patients with metabolic syndrome. In our current research we have modeled the outcomes of metabolic syndrome treatment using two distinct drug classes. Methods Targets were ...
In humans and mammals, alcohol dehydrogenase and aldehyde dehydrogenase (ALDH) constitute the alcohol dehydrogenase system, which is involved in ethanol metabolism in vivo and is an important metabolic enzyme in humans and animals. As a key enzyme in the metabolism of major short-chain alcohols in organisms, it plays an important role in many ...
(B&C®), was quoted by the Bloomberg BNA Daily Environment Report in the article “FDA Pushes Risk-Based Approach to Nanomaterial Drugs.” Developers of drugs containing nanomaterials—substances so small they can't be seen with a regular microscope—got some advice on how to assess their risks in FDA draft guidance issued Dec. 15. ...
Background This final report, Use of Physiologically Based Pharmacokinetic Models to Quantify the Impact of Human Age and Interindividual Differences in Physiology and Biochemistry Pertinent to Risk Final Report for Cooperative Agreement (PDF, 234 pp, 1MB), addresses the quantification, extrapolation and interpretation of advanced biochemical information on human ...